Rouan Sarah Kathryn bought Viking Therapeutics ($VKTX) shares on the open market twice in the last year, totaling nearly $60,000. Her most recent purchase occurred on March 31, 2025. Among nearly 5,000 insiders tracking open market buys, her total ranks 2,817th, well below the average of $1.46 million across 3.3 transactions per person. She reported no open market sales in the past year.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Not found | A | Common Stock, par value $0.00001 per share | 3150 | $0.00 | 4,390.0000 | 113,036,344 | 254.03% | 0.00% |
| Jan. 2, 2026 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 113,036,344 | 9999.99% | 0.02% |
| March 31, 2025 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Not found | P | Common Stock, par value $0.00001 per share | 1240 | $24.15 | 1,240.0000 | 112,247,809 | 9999.99% | 0.00% |
| March 31, 2025 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Not found | P | Common Stock, par value $0.00001 per share | 1240 | $24.15 | 1,240.0000 | 112,247,809 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Not found | A | Stock Option (Right to Buy) | 18800 | $0.00 | 18,800.0000 | 0 | 9999.99% | 0.00% |
| Oct. 25, 2024 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Not found | M | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 0 | 50.00% | 0.00% |
| Oct. 25, 2024 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Not found | S | Common Stock, par value $0.00001 per share | 11000 | $80.89 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 25, 2024 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Not found | M | Common Stock, par value $0.00001 per share | 11000 | $4.88 | 11,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Director | M | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2024 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Director | M | Common Stock, par value $0.00001 per share | 25000 | $8.32 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Director | S | Common Stock, par value $0.00001 per share | 25000 | $28.05 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 19, 2024 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Director | S | Common Stock, par value $0.00001 per share | 30000 | $23.05 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 19, 2024 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Director | M | Stock Option (Right to Buy) | 30000 | $0.00 | 25,000.0000 | 0 | 54.55% | 0.00% |
| Jan. 19, 2024 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Director | M | Common Stock, par value $0.00001 per share | 30000 | $8.32 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Viking Therapeutics, Inc. | $VKTX | Rouan Sarah Kathryn | Director | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |